← Open Payments lookup

CHRISTOPHER TIKUM: Open Payments

NPI 1578269056 · EAST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,955 in 191 payments from 12 companies in 2025. Trend: 2023 $590 · 2024 $1,500 · 2025 $2,955

Food & beverage: $2,944Education: $11
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)60$978
Alkermes, Inc.36$677
Neurocrine BioSciences, Inc.40$516
ABBVIE INC.16$196
E.R. Squibb & Sons, L.L.C.15$162
Otsuka America Pharmaceutical, Inc.8$152
Lundbeck LLC6$107
Teva Pharmaceuticals USA, Inc.3$51
Vanda Pharmaceuticals Inc.3$47
Axsome Therapeutics, Inc.2$32

Products named: CAPLYTA, ARISTADA, INGREZZA, REXULTI, VRAYLAR, COBENFY, HETLIOZ, AUSTEDO XR.

Industry payments across NJ — which companies pay providers there.